BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/29/2024 8:28:54 AM | Browse: 56 | Download: 203
 |
Received |
|
2024-03-13 08:36 |
|
Peer-Review Started |
|
2024-03-13 08:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-07-09 02:01 |
|
Revised |
|
2024-07-19 13:24 |
|
Second Decision |
|
2024-08-02 02:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-08-02 07:20 |
|
Articles in Press |
|
2024-08-02 07:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-21 06:18 |
|
Publish the Manuscript Online |
|
2024-08-29 08:28 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Advanced glycation end products in gastric cancer: A promising future
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Meng-Hui Wang, Hui Fang and Chuan Xie |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The National Natural Science Foundation of China |
No. 82100599 |
| The National Natural Science Foundation of China |
No. 81960112 |
| The Jiangxi Provincial Department of Science and Technology |
No. 20212ACB216003 |
| The Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine |
No.2023Z021 |
| The Young Talents Project of Jiangxi Provincial Academic and Technical Leaders Training Program for Major Disciplines |
No. 20204BCJ23022 |
|
| Corresponding Author |
Chuan Xie, MD, Chief Doctor, Teacher, Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, The Jiangxi Medical College, The Nanchang University, No.17 Yongwaizheng Street, Nanchang 330006, Jiangxi Province, China. xcsghhz@ncu.edu.cn |
| Key Words |
Advanced glycation end products; Gastric cancer; Receptor of advanced glycation end products; Prognosis; Therapeutic approaches |
| Core Tip |
Gastric cancer is a widespread malignancy that is linked to multiple risk factors. Advanced glycation end products (AGEs) are closely correlated with gastric cancer pathogenesis. Decreasing AGEs levels and minimizing AGEs accumulation may slow gastric cancer progression. Future research endeavours should aim to discover novel interventions to reduce the burden of gastric cancer and improve human health. |
| Publish Date |
2024-08-29 08:28 |
| Citation |
<p>Wang MH, Fang H, Xie C. Advanced glycation end products in gastric cancer: A promising future. <i>World J Clin Oncol</i> 2024; 15(9): 1117-1121</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i9/1117.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i9.1117 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
